期刊文献+

罗格列酮对糖尿病大鼠血管内皮损伤的保护作用与一氧化氮合酶抑制物的关系 被引量:8

Protective effect of rosiglitazone on endothelial cells and endogenous nitric oxide synthase inhibitor in diabetic rats
下载PDF
导出
摘要 目的研究罗格列酮对链脲佐菌素(STZ)诱导的1型糖尿病大鼠血管内皮损伤的保护作用与内源性一氧化氮合酶(NOS)抑制物的关系。方法SD大鼠单次腹腔注射STZ(60mg·kg-1)诱发实验性1型糖尿病,检测血中血糖、血脂、非对称性二甲基精氨酸(ADMA)、肿瘤坏死因子-α(TNF-α)含量,并观察离体主动脉环的内皮依赖性舒张反应;ADMA孵育内皮细胞,检测细胞培养液中TNF-α。结果实验性1型糖尿病大鼠胸主动脉对乙酰胆碱(Ach)诱导的血管内皮依赖性舒张效应显著减弱,血中TNF-α与ADMA浓度显著升高,罗格列酮能显著改善糖尿病大鼠内皮依赖性舒张功能,降低血中TNF-α浓度,但不影响血脂、血糖与ADMA水平。在培养的人脐静脉内皮细胞,ADMA能显著升高培养液中TNF-α水平,罗格列酮(10,30μmol·L-1)能显著抑制TNF-α水平的升高。结论罗格列酮能改善链脲佐菌素诱导的1型糖尿病大鼠血管内皮依赖性舒张功能,其机制与抑制ADMA的致炎作用有关。 OBJECTIVE To determine the relationship between protective effect of rosiglitazone on the endothelium in streptozotocin-induced diabetic rats and endogenous nitric oxide synthase inhibitor. METHODS Diabetes was induced by a single intraperitoneal injection of streptozotocin(60 mg·kg~ -1) in Sprague-Dawley rats. Vasodilator responses to acetylcholine (Ach) in the isolated aortic rings were measured,and serum concentrations of glucose,lipid,nitric oxide(NO),asymmetric dimethylarginine (ADMA),and tumour necrosis factor-α (TNF-α) were determined. Human umbilical vein endothelial cell was cultured with ADMA and the concentration of TNF-α in the cultured medium was measured. RESULTS Vasodilator responses to Ach were decreased markedly and the serum concentrations of ADMA and TNF-α were increased significantly in streptozotocin-induced diabetic rats. Rosiglitazone (3,10 or 30 mg·kg~ -1) markedly reduced the inhibition of vasodilator responses to Ach and decreased the serum concentration of INF-α in diabetic rats,but had no effect on the serum concentrations of glucose,lipid and ADMA in diabetic rats. Incubation of HUECV with ADMA(30 μmol·L~ -1)significantly increased the concentration of TNF-α in the cultured medium,which was inhibited in the presence of rosiglitazone (10 or 30 μmol·L~ -1). CONCLUSIONS Rosiglitazone improves the endothelial function in streptozotocin-induced diabetic rats,and the protective effect of rosiglitazone on endothelium is related to the reduction of inflammatory reaction induced by ADMA.
出处 《中南药学》 CAS 2005年第3期131-135,共5页 Central South Pharmacy
基金 教育部高等学校博士学科点专项科研基金(200220533034)
关键词 罗格列酮 非对称性二甲基精氨酸 肿瘤坏死因子-Α 糖尿病 大鼠 rosiglitazone asymmetric dimethylarginine (ADMA) tumour necrosis factor-α(TNF-α) diabetes mellitus rat
  • 相关文献

参考文献16

  • 1[1]Xiong Y,Fu YF,Fu SH,et al. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes [J].J Cardiovasc Pharmacol,2003,42(2):191
  • 2[2]Boger RH,Bode-Boger SM,Tsao PS,et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].J Am Coll Cardiol,2000,36(7): 2287
  • 3[3]Pistrosch F,Passauer J,Fischer S,et al. In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control [J].Diabetes Care,2004,27(2):484
  • 4[4]Stuhlinger MC,Abbasi F,Chu JW,et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor[J].JAMA,2002,287(11):1420
  • 5[5]Pasceri V,Wu HD,Willerson JT,et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators[J].Circulation,2000,101(3):235
  • 6[6]Diep QN,El Mabrouk M,Cohn JS,et al. Structure,endothelial function,cell growth,and inflammation in blood vessels of angiotensin Ⅱ-infused rats: role of peroxisome proliferator-activated receptor-gamma[J].Circulation,2002,105(19): 2296
  • 7[7]Jiang JL,Li NS,Li YJ,et al. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthases inhibitor level [J].Br J Pharmacol,2002,135 (5): 1175
  • 8[8]Calver A,Collier J,Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes[J].J Clin Invest,1992,90(6): 2548
  • 9[9]Tilton RG,Chang K,Hasan KS,et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation [J].Diabetes,1993,42(2): 221
  • 10罗谋伦,郭欲晓,胡映辉,林志彬.罗格列酮的胰岛素增敏作用和胰岛素抵抗改善作用[J].中国药理学通报,2000,16(4):425-428. 被引量:12

二级参考文献3

  • 1胡良平,现代统计学与SAS应用,1996年,150页
  • 2卫生部医政局,全国临床检验操作规程,1991年,159页
  • 3罗谋伦,郭欲晓,林志彬.大鼠正糖钳实验方法学[J].药学学报,1999,34(4):255-259. 被引量:13

共引文献11

同被引文献79

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部